Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on GoHealth (GOCO – Research Report), Viridian Therapeutics (VRDN – Research Report) and Xenon (XENE – Research Report).
GoHealth (GOCO)
In a report issued on August 11, Ben Hendrix from RBC Capital maintained a Hold rating on GoHealth, with a price target of $20.00. The company’s shares closed last Friday at $19.12.
According to TipRanks.com, Hendrix is a 1-star analyst with an average return of
Currently, the analyst consensus on GoHealth is a Moderate Sell with an average price target of $10.00.
See Insiders’ Hot Stocks on TipRanks >>
Viridian Therapeutics (VRDN)
RBC Capital analyst Gregory Renza maintained a Buy rating on Viridian Therapeutics on August 8 and set a price target of $44.00. The company’s shares closed last Friday at $19.62.
According to TipRanks.com, Renza is a 4-star analyst with an average return of
Viridian Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $43.45, a 122.6% upside from current levels. In a report issued on August 9, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $36.00 price target.
Xenon (XENE)
In a report issued on August 9, Brian Abrahams from RBC Capital maintained a Buy rating on Xenon, with a price target of $51.00. The company’s shares closed last Friday at $37.70.
According to TipRanks.com, Abrahams is a 4-star analyst with an average return of
Currently, the analyst consensus on Xenon is a Strong Buy with an average price target of $55.17, a 44.3% upside from current levels. In a report issued on August 9, Goldman Sachs also assigned a Buy rating to the stock with a $60.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GOCO:
